Fidelity Investments’s Harvard Bioscience HBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.1K | Buy |
72,274
+49,246
| +214% | +$21.9K | ﹤0.01% | 4095 |
|
|
2025
Q1 | $13K | Buy |
23,028
+17,919
| +351% | +$10.1K | ﹤0.01% | 4395 |
|
|
2024
Q4 | $10.8K | Buy |
5,109
+805
| +19% | +$1.7K | ﹤0.01% | 4445 |
|
|
2024
Q3 | $11.6K | Buy |
4,304
+54
| +1% | +$145 | ﹤0.01% | 4376 |
|
|
2024
Q2 | $12.1K | Buy |
4,250
+4,191
| +7,103% | +$11.9K | ﹤0.01% | 4257 |
|
|
2024
Q1 | $250 | Sell |
59
-206
| -78% | -$873 | ﹤0.01% | 4902 |
|
|
2023
Q4 | $1.42K | Buy |
265
+217
| +452% | +$1.16K | ﹤0.01% | 4705 |
|
|
2023
Q3 | $206 | Buy |
48
+8
| +20% | +$34 | ﹤0.01% | 4787 |
|
|
2023
Q2 | $220 | Buy |
+40
| New | +$220 | ﹤0.01% | 4892 |
|
|
2022
Q3 | – | Sell |
-367
| Closed | -$1K | – | 5110 |
|
|
2022
Q2 | $1K | Sell |
367
-1,008
| -73% | -$2.75K | ﹤0.01% | 4720 |
|
|
2022
Q1 | $8K | Buy |
1,375
+982
| +250% | +$5.71K | ﹤0.01% | 4293 |
|
|
2021
Q4 | $3K | Buy |
+393
| New | +$3K | ﹤0.01% | 3928 |
|
|
2016
Q2 | – | Sell |
-107,384
| Closed | -$324K | – | 2665 |
|
|
2016
Q1 | $324K | Buy |
107,384
+11,600
| +12% | +$35K | ﹤0.01% | 2587 |
|
|
2015
Q4 | $332K | Hold |
95,784
| – | – | ﹤0.01% | 2649 |
|
|
2015
Q3 | $362K | Sell |
95,784
-460,234
| -83% | -$1.74M | ﹤0.01% | 2621 |
|
|
2015
Q2 | $3.17M | Buy |
556,018
+459,134
| +474% | +$2.62M | ﹤0.01% | 2357 |
|
|
2015
Q1 | $564K | Hold |
96,884
| – | – | ﹤0.01% | 2597 |
|
|
2014
Q4 | $549K | Buy |
+96,884
| New | +$549K | ﹤0.01% | 2624 |
|
|
2013
Q3 | – | Sell |
-1,507,612
| Closed | -$7.13M | – | 2637 |
|
|
2013
Q2 | $7.13M | Buy |
+1,507,612
| New | +$7.13M | ﹤0.01% | 2032 |
|